A Pennsylvania-based pharmaceutical firm and the FDA issued a recall of an injectable blood pressure medicine after a customer noticed “a visible black particulate matter” in a vial. Dr. Bernard Ashby says patients should discuss concerns with their pharmacist or anesthesiologist before procedures to ensure the drug is safe. #bloodpressure #FDA #health
